ClinicalTrials.gov
public full text
Public Domain
Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
This study will be an observational cohort study utilizing administrative claims data with 100 patients randomly selected taking Metanx® meeting the inclusion and exclusion criteria and 400 propensity score matched patients meeting the same criteria to serve as a control cohort for analyses. This data includes medical, and pharmacy claims from the HealthCore Integrated Research Database for claims submitted during the time period of 01/01/2002 through 06/30/2007.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prevalence, Hallmark-Based Mechanisms, and Risk Factors of Peripheral Diabetic Neuropathy: A Systematic Review and Meta-Analysis.#633118
- The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)#914491
- Comprehensive risk analysis of diabetic peripheral neuropathy in type II diabetes mellitus.#196041
- Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx®#474883
- Effects of exercise interventions to reduce chemotherapy-induced peripheral neuropathy severity: A meta-analysis#947712
Record · ID 1308192
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive